Please Wait.....
Report
Diabetic Ketoacidosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Insulin Therapy, Electrolyte Replacement, Fluid Replacement), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others) By Region & Competition, 2020-2030F
Market Report I 2025-05-16 I 185 Pages I TechSci Research
Market Overview
The Global Diabetic Ketoacidosis (DKA) Market was valued at USD 3.24 Billion in 2024 and is expected to reach USD 4.42 Billion by 2030, growing at a CAGR of 5.35% during the forecast period. DKA is a severe, potentially life-threatening complication of diabetes, particularly Type 1, characterized by elevated blood glucose levels and ketone buildup. The market includes a broad range of pharmaceuticals, diagnostics, and medical devices designed to prevent and manage DKA episodes effectively. With diabetes affecting one in ten adults globally-as reported by the International Diabetes Federation in 2022-DKA remains a pressing concern in clinical settings. Key contributors to market growth include rising diabetes incidence, growing adoption of advanced glucose monitoring technologies, and innovations in insulin therapy. Developments such as ultra-rapid-acting insulins and integrated insulin delivery systems have improved treatment outcomes, while innovations in continuous glucose monitoring and point-of-care diagnostics have enhanced disease management and early DKA detection. As a result, the market is evolving quickly to meet the increasing demand for effective DKA solutions across diverse healthcare environments.
Key Market Drivers
Rising Prevalence of Diabetes
The growing global burden of diabetes is a major factor fueling the expansion of the DKA market. According to the International Diabetes Federation, 537 million individuals were living with diabetes in 2021, a figure projected to rise to 643 million by 2030. Among these, patients with Type 1 diabetes are especially vulnerable to DKA, emphasizing the need for comprehensive management strategies. Factors contributing to the rising incidence include sedentary lifestyles, poor dietary habits, urbanization, and genetic susceptibility. In the United States alone, the CDC reports over 34 million people with diabetes, both diagnosed and undiagnosed. With prediabetes also on the rise, the risk of DKA episodes is increasing, creating sustained demand for effective monitoring tools, insulin therapy, and emergency care solutions.
Key Market Challenges
Limited Access to Healthcare Services
Access to healthcare services remains a critical challenge in addressing DKA, particularly in low-income and rural regions. In these areas, limited availability of trained medical personnel, diagnostic tools, and essential medicines such as insulin hampers effective diabetes management. As a result, patients often experience delayed diagnosis and poor glycemic control, increasing their risk of developing DKA. The high cost of diabetes care-including insulin, blood glucose monitors, and regular medical supervision-further restricts access, forcing many to compromise their treatment. This disparity not only leads to increased hospitalizations and complications but also highlights the need for more equitable and affordable healthcare infrastructure to prevent DKA globally.
Key Market Trends
Technological Advancements in Glucose Monitoring
Technological innovation in glucose monitoring is transforming the landscape of DKA prevention and management. Continuous Glucose Monitoring (CGM) systems provide real-time insights into blood glucose trends, helping patients and providers detect early signs of hyperglycemia. This allows for timely intervention and reduces the likelihood of DKA episodes. CGM systems offer advantages such as trend analysis, alert notifications, and historical data tracking, which support improved insulin dosing and lifestyle adjustments. These features empower patients to manage their condition more proactively. In parallel, the rise of smart insulin pumps and integrated digital health platforms is enhancing the precision and convenience of insulin delivery, contributing to better DKA management outcomes.
Key Market Players
- Novo Nordisk AS
- Baxter Healthcare Corporation
- B. Braun Medical Inc.
- ICU Medical, Inc.
- Pfizer Inc.
- Merit Pharmaceutical
- SteriCare Solutions
- Soxa Formulations & Research (Pvt.) Ltd
- BD company
- Fresenius Kabi USA
Report Scope:
In this report, the Global Diabetic Ketoacidosis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Diabetic Ketoacidosis Market, By Treatment:
o Insulin Therapy
o Electrolyte Replacement
o Fluid Replacement
- Diabetic Ketoacidosis Market, By End User:
o Hospitals & Clinics
o Ambulatory Care Centers
o Others
- Diabetic Ketoacidosis Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Diabetic Ketoacidosis Market.
Available Customizations:
Global Diabetic Ketoacidosis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Diabetic Ketoacidosis Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Treatment (Insulin Therapy, Electrolyte Replacement, Fluid Replacement)
4.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
4.2.3. By Region
4.2.4. By Company (2024)
4.3. Market Map
4.3.1. By Treatment
4.3.2. By End User
4.3.3. By Region
5. Asia Pacific Diabetic Ketoacidosis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment
5.2.2. By End User
5.2.3. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Diabetic Ketoacidosis Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Treatment
5.3.1.2.2. By End User
5.3.2. India Diabetic Ketoacidosis Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Treatment
5.3.2.2.2. By End User
5.3.3. Australia Diabetic Ketoacidosis Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Treatment
5.3.3.2.2. By End User
5.3.4. Japan Diabetic Ketoacidosis Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Treatment
5.3.4.2.2. By End User
5.3.5. South Korea Diabetic Ketoacidosis Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Treatment
5.3.5.2.2. By End User
6. Europe Diabetic Ketoacidosis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment
6.2.2. By End User
6.2.3. By Country
6.3. Europe: Country Analysis
6.3.1. France Diabetic Ketoacidosis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Treatment
6.3.1.2.2. By End User
6.3.2. Germany Diabetic Ketoacidosis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Treatment
6.3.2.2.2. By End User
6.3.3. Spain Diabetic Ketoacidosis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Treatment
6.3.3.2.2. By End User
6.3.4. Italy Diabetic Ketoacidosis Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Treatment
6.3.4.2.2. By End User
6.3.5. United Kingdom Diabetic Ketoacidosis Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Treatment
6.3.5.2.2. By End User
7. North America Diabetic Ketoacidosis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment
7.2.2. By End User
7.2.3. By Country
7.3. North America: Country Analysis
7.3.1. United States Diabetic Ketoacidosis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment
7.3.1.2.2. By End User
7.3.2. Mexico Diabetic Ketoacidosis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment
7.3.2.2.2. By End User
7.3.3. Canada Diabetic Ketoacidosis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment
7.3.3.2.2. By End User
8. South America Diabetic Ketoacidosis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment
8.2.2. By End User
8.2.3. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Diabetic Ketoacidosis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment
8.3.1.2.2. By End User
8.3.2. Argentina Diabetic Ketoacidosis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment
8.3.2.2.2. By End User
8.3.3. Colombia Diabetic Ketoacidosis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment
8.3.3.2.2. By End User
9. Middle East and Africa Diabetic Ketoacidosis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment
9.2.2. By End User
9.2.3. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Diabetic Ketoacidosis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment
9.3.1.2.2. By End User
9.3.2. Saudi Arabia Diabetic Ketoacidosis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment
9.3.2.2.2. By End User
9.3.3. UAE Diabetic Ketoacidosis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment
9.3.3.2.2. By End User
9.3.4. Egypt Diabetic Ketoacidosis Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Treatment
9.3.4.2.2. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Diabetic Ketoacidosis Market: SWOT Analysis
13. Porter's Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. Novo Nordisk AS
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Baxter Healthcare Corporation
14.3. B. Braun Medical Inc.
14.4. ICU Medical, Inc.
14.5. Pfizer Inc.
14.6. Merit Pharmaceutical
14.7. SteriCare Solutions
14.8. Soxa Formulations & Research (Pvt.) Ltd
14.9. BD company
14.10. Fresenius Kabi USA
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security